[China Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal HONG KONG, China, April 29, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated] [FORM 6-K CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On April 2 9 Description]

[China Cord Blood Corporation Announces Receipt of “Going Private” Proposal The Company expects that its board of directors will form a special committee of independent directors (the “Special Committee”) to consider the proposed transaction. The Company also expects that the Special Committee will retain advisors, including an independent financial advisor and legal counsel, to assist it in its work. The] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]

[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 3Q15 Added 17,622 New Subscribers 3Q15 Revenue Up 10.7% YOY to RMB166.7 Million ($26.9 Million) 3Q15 Operating Income Increased to RMB67.8 Million ($10.9 Million) Conference Call to be Held February 26, 2015 at 8:00 a.m. ET HONG KONG, China, February 25, 2015] [FORM 6-K For the month of February 2015 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x Form 40-F o o o Yes o No x EXPLANATORY NOTE Report on Report on Form 6-K are subject to risks, uncertainties and assumptions about the Company’s businesses and business environments. These statements reflect the Company’s current views]